171 related articles for article (PubMed ID: 1877710)
1. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
[TBL] [Abstract][Full Text] [Related]
2. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.
Feighny R; Burrous J; Putnak R
Am J Trop Med Hyg; 1994 Mar; 50(3):322-8. PubMed ID: 8147490
[TBL] [Abstract][Full Text] [Related]
3. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
[TBL] [Abstract][Full Text] [Related]
4. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
5. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.
Eckels KH; Dubois DR; Summers PL; Schlesinger JJ; Shelly M; Cohen S; Zhang YM; Lai CJ; Kurane I; Rothman A
Am J Trop Med Hyg; 1994 Apr; 50(4):472-8. PubMed ID: 8166355
[TBL] [Abstract][Full Text] [Related]
6. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice.
Staropoli I; Frenkiel MP; Mégret F; Deubel V
Vaccine; 1997 Dec; 15(17-18):1946-54. PubMed ID: 9413106
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.
Delenda C; Frenkiel MP; Deubel V
Arch Virol; 1994; 139(1-2):197-207. PubMed ID: 7826210
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
[TBL] [Abstract][Full Text] [Related]
9. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue.
Deubel V; Kinney RM; Esposito JJ; Cropp CB; Vorndam AV; Monath TP; Trent DW
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1921-9. PubMed ID: 3404119
[TBL] [Abstract][Full Text] [Related]
10. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
12. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
13. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.
Srivastava AK; Putnak JR; Warren RL; Hoke CH
Vaccine; 1995 Sep; 13(13):1251-8. PubMed ID: 8578812
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines.
Velzing J; Groen J; Drouet MT; van Amerongen G; Copra C; Osterhaus AD; Deubel V
Vaccine; 1999 Mar; 17(11-12):1312-20. PubMed ID: 10195766
[TBL] [Abstract][Full Text] [Related]
15. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.
Deubel V; Bordier M; Megret F; Gentry MK; Schlesinger JJ; Girard M
Virology; 1991 Jan; 180(1):442-7. PubMed ID: 1984665
[TBL] [Abstract][Full Text] [Related]
16. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
17. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
[TBL] [Abstract][Full Text] [Related]
18. Expression of avian leukaemia virus env-gp85 in Spodoptera frugiperda cells by use of a baculovirus expression vector.
Noteborn MH; de Boer GF; Kant A; Koch G; Bos JL; Zantema A; van der Eb AJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2641-8. PubMed ID: 2174957
[TBL] [Abstract][Full Text] [Related]
19. Immune protection conferred by the baculovirus-related glycoprotein of Thogoto virus (Orthomyxoviridae).
Jones LD; Morse MA; Marriott AC; Nuttall PA
Virology; 1995 Oct; 213(1):249-53. PubMed ID: 7483270
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system.
Qu X; Chen W; Maguire T; Austin F
J Gen Virol; 1993 Jan; 74 ( Pt 1)():89-97. PubMed ID: 8423452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
